Simplex Trading’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,200
Closed -$1K 11020
2022
Q3
$1K Sell
4,200
-200
-5% -$87 ﹤0.01% 9753
2022
Q2
$3K Buy
+4,400
New +$3.92K ﹤0.01% 9268
2022
Q1
Sell
-2,000
Closed -$3K 11806
2021
Q4
$3K Sell
2,000
-12,600
-86% -$30.2K ﹤0.01% 9924
2021
Q3
$58K Hold
14,600
﹤0.01% 7350
2021
Q2
$57K Buy
14,600
+14,558
+34,662% +$60.4K ﹤0.01% 7493
2021
Q1
$21K Sell
42
-10
-19% -$52 ﹤0.01% 7432
2020
Q4
$21K Buy
52
+49
+1,633% +$241 ﹤0.01% 6961
2020
Q3
$1K Buy
+3
New +$16 ﹤0.01% 7633
2019
Q2
Sell
-15
Closed -$6K 8065
2019
Q1
$6K Hold
15
﹤0.01% 6438
2018
Q4
$3K Buy
15
+12
+400% +$70 ﹤0.01% 6489
2018
Q3
$2K Buy
+3
New +$13 ﹤0.01% 7124
2017
Q4
Sell
-3
Closed -$2K 6932
2017
Q3
$2K Buy
+3
New +$14 ﹤0.01% 5223
2017
Q2
Sell
-10
Closed -$3K 7031
2017
Q1
$3K Buy
+10
New +$78 ﹤0.01% 5105

Simplex Trading's AGTC Position: Q4 2022 in Review

Simplex Trading sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 20,259 shares — an estimated $5K sold.

Simplex Trading first reported a position in AGTC in Q1 2017 and held it in 10 quarters. The position peaked at $96K in Q3 2020. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.

  • Simplex Trading reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
  • Simplex Trading sold 20,259 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $5K.
  • Simplex Trading first reported a position in Applied Genetic Technologies Corporation in Q1 2017 and held it in 10 quarters.
  • Simplex Trading's Applied Genetic Technologies Corporation position peaked at $96K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.